Prezzo di chiusura
Altri mercati azionari
|
||
- USD | - |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15/09/15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19/01/23 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 01/11/18 |
Alicia Tozier
SAM | Sales & Marketing | - | 02/03/22 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 08/02/22 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 01/11/18 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 26/04/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13/04/18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11/12/15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15/09/15 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 31/10/17 |
Julian Gangolli
BRD | Director/Board Member | 66 | 20/04/20 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 20/04/20 |
Julia Haller
BRD | Director/Board Member | 69 | 11/08/22 |
Director/Board Member | 39 | 11/09/17 | |
Andong Huang
BRD | Director/Board Member | 27 | 19/06/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 23 405 637 | 14 743 307 ( 62,99 %) | 0 | 62,99 % |
Coordinate società
Outlook Therapeutics, Inc.
111 South Wood Avenue Unit 100
08830, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+21,57% | 46,93 Mrd | |
+37,63% | 39,08 Mrd | |
-8,39% | 38,48 Mrd | |
+29,12% | 31,01 Mrd | |
-13,75% | 26,14 Mrd | |
+11,28% | 25,88 Mrd | |
+35,90% | 12,53 Mrd | |
-6,68% | 11,36 Mrd | |
-12,37% | 10,65 Mrd |
- Borsa valori
- Azioni
- Azione OTLK
- Azione
- Società Oncobiologics Inc